Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Nanomedicine design of particles, sensors, motors, implants, robots, and devices / / Mark J. Schulz, Vesselin N. Shanov, Yeoheung Yun, editors
| Nanomedicine design of particles, sensors, motors, implants, robots, and devices / / Mark J. Schulz, Vesselin N. Shanov, Yeoheung Yun, editors |
| Pubbl/distr/stampa | Boston : , : Artech House, , ©2009 |
| Descrizione fisica | 1 online resource (548 p.) |
| Disciplina |
610.28
610.284 |
| Altri autori (Persone) |
SchulzMark J
ShanovVesselin N YunYeoheung |
| Collana | Artech House series engineering in medicine & biology |
| Soggetto topico |
Nanomedicine
Nanotechnology |
| ISBN | 1-59693-280-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Nanomedicine Design of Particles, Sensors, Motors, Implants, Robots, and Devices; Contents; Preface; Chapter 1 A Nanotechnology Framework for Medical Innovation; 1.1 Introduction; 1.2 Descriptive Systems Modeling; 1.2.1 Examples of Descriptive Systems Modeling; 1.3 Instrumentation Needed to Develop DSM; 1.4 Nanomaterials Made for Medicine; 1.5 Implantable Nanomedical Devices; 1.6 Nanorobots; 1.6.1 Nanorobots for Revolutionizing Medicine; 1.6.2 Nanorobot Factory; 1.6.3 Biological Nanorobots; 1.7 Biodegradable Metals for Temporary Implantable Nanomedical Devices
1.8 Integration of Nanodevices in the Body1.9 Safety and Ethical Implications of Nanomedicine; 1.10 Efficiently Working Together Using Shared Resources; 1.11 Chapter Summary and Conclusions; Problems; Acknowledgments; References; Endnote; Part 1 Nanoscale Materials and Particles; Chapter 2 Synthesis of Carbon Nanotube Materials for Biomedical Applications; 2.1 Introduction to Nanoscale Materials; 2.2 Synthesis of Long Carbon Nanotube Arrays; 2.3 Characterization of CNT Arrays; 2.3.1 Scanning Electron Microscopy and Transmission Electron Microscopy 2.3.2 Raman Spectroscopy and Thermal Gravimetric Analysis2.4 Patterned CNT Arrays; 2.5 Production Scale Up of CNT Arrays at UC; 2.5.1 Magnetron Sputtering for Substrate Preparation; 2.6 Spinning Carbon Nanotubes into Thread; 2.6.1 Mechanics of Array Spinning; 2.6.2 Direct Spinning of Thread from Long CNT Arrays; 2.6.3 Catalyst and Substrates for Growing of Spinable CNT Arrays; 2.6.4 Spinning Thread from DWCNT Arrays; 2.6.5 Pulling Ribbon from CNT Arrays; 2.6.6 Post-Treatment of the CNT Thread; 2.7 Mechanical and Electrical Characterization of CNT Thread; 2.7.1 Tensile Testing of CNT Thread 2.7.2 Electrical Properties of CNT Thread2.7.3 Temperature Dependence of the CNT Thread Resistance; 2.7.4 Electrical Properties of CNT Ribbon; 2.8 Nano-Handling of CNTs Using a Nanomanipulator Inside an ESEM; 2.8.1 Instrumentation; 2.8.2 Handling CNT Bundles; 2.8.3 Building Nanomedical Devices Using the Nanomanipulator; 2.9 Carbon Nanotube Threads in Wireless, Biomedical Sensor Applications; 2.9.1 Wireless Communication and the Modern World; 2.9.2 Development of CNT Thread-Based Antenna at UC; 2.9.3 Future Medical Application of the CNT Thread Antenna 2.10 Applications of CNT Materials in Nanomedicine2.10.1 Carbon Nanotube Array Immunosensor; 2.10.2 Carbon Nanotube Actuators; 2.10.3 Carbon Nanotube Materials as Scaffolds for Supporting Directional Neurite Growth; 2.11 Summary and Conclusions; Problems; Acknowledgments; References; Chapter 3 Functionalized Carbon Nanotubes as Multimodal Drug Delivery Systems for Targeted Cancer Therapy; 3.1 Introduction to Targeted Cancer Therapy; 3.1.1 Cancer Statistics; 3.1.2 Present-Day Cancer Treatment and Associated Problems; 3.1.3 A Brief Insight into Targeting Strategies 3.2 Carbon Nanotubes: A Versatile Material |
| Record Nr. | UNINA-9910809813903321 |
| Boston : , : Artech House, , ©2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine for cancer diagnosis and therapy / / Arshi Malik, Sarah Afaq and Mohammed Tarique (editors)
| Nanomedicine for cancer diagnosis and therapy / / Arshi Malik, Sarah Afaq and Mohammed Tarique (editors) |
| Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (251 pages) |
| Disciplina | 616.994075 |
| Soggetto topico |
Nanomedicine
Cancer - Treatment - Technological innovations Nanomedicina Oncologia Terapèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-15-7564-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Contents -- About the Editors -- 1: Nanoparticles for Cancer Therapy -- 1.1 Introduction -- 1.1.1 Cancer and its Types -- 1.1.2 Nanomedicine -- 1.2 Evolution of Cancer Therapy -- 1.2.1 Surgery and Adjuvant Therapies -- 1.2.2 Hormone Therapy -- 1.2.3 Immunotherapy -- 1.2.4 Cancer Therapy with Nanomedicine -- 1.3 Nanoparticles in Cancer Therapy -- 1.3.1 Protein Nanoparticles -- 1.3.2 Magnetic Nanoparticles -- 1.3.3 Inorganic Nanoparticles -- 1.3.4 Lipid Nanoparticles -- 1.3.5 Targeted Nanoparticles -- 1.3.6 Polymeric Nanoparticles -- 1.3.7 Multifunctional Nanoparticles -- 1.3.8 Quantum Dots -- 1.3.9 DNA Nanoparticles -- 1.4 Pharmacokinetics of Cancer Nanodrug Carriers -- 1.5 Cancer Nanomedical Research -- 1.5.1 Initial Advancements in Nanoparticle Research -- 1.5.2 Nanomedical Research Using Plant-Derived Compounds -- 1.5.3 Nanomedical Research Using Gene Therapeutic Strategies -- 1.5.4 Nanomedical Research Using In Vivo Imaging Techniques -- 1.5.5 Mainstream Research in the ``Golden Age´´ of Nanotechnology -- 1.5.6 Nanomedical Research Using Computational and Nanobioinformatic Tools -- 1.6 Nanomedicine in Cancer Diagnosis and Treatment -- 1.6.1 Immunoassays Using Nanomaterial-Embedded Microchips -- 1.6.2 In Vivo Imaging Using Nanoparticle Contrast Agents -- 1.6.3 Theranostic Nanomedicine -- 1.6.4 Cancer Nanodrug Release Systems and Personalized Cancer Nanomedicine -- 1.7 Current Research and Prospects -- 1.7.1 Smart Nanocarrier-Based Drug-Delivery Systems for Cancer Therapy -- 1.7.2 RNA Delivery Using Nanoparticles -- 1.7.3 Nanobots -- 1.8 Concluding Remarks -- References -- 2: Strategies for Improving the Efficiency of Nanomaterials -- 2.1 Introduction -- 2.2 Strategies for the Improvement of Nanomaterials -- 2.2.1 Photocatalytic Efficiency -- 2.2.2 Therapeutic Efficiency.
2.2.2.1 Strategic Improvement of Nanomaterials for Enhanced Permeability and Retention (EPR) Effects -- 2.2.2.2 Strategic Improvement of Nanomedicine for Improved Drug Delivery Systems -- Liposome Based Nanoformulation -- Nanoemulsions -- Solid Lipid Nanoparticles (SLN) -- Strategies for Organelles Specific Targeting of Nanodrugs -- Virus Based Nanoformulation -- 2.2.2.3 Photoactivated Nanomaterials for Photodynamic and Photothermal Therapy (PDT/PTT) -- 2.2.2.4 Mesoporous Silica Nanoparticles (MSNP) -- 2.2.2.5 Dendrimers -- 2.2.3 Engineering Nanoparticles to Evade the Multidrug Resistance (MDR) in Cancer -- 2.2.4 Nanoparticle-Based Combination Therapy -- 2.3 Conclusion -- References -- 3: Bioinspired Nanoparticles in Cancer Theranostics -- 3.1 Introduction -- 3.2 Novelty of Bioinspired Nanoparticles Based Theranostics -- 3.2.1 Liposomes in Cancer Theranostics -- 3.2.2 Lipid Nanoparticles in Cancer Theragnostic -- 3.2.2.1 Solid Lipid Nanoparticles (SLNs) -- 3.2.2.2 Nano-Structured Lipids (NLCs) -- 3.2.2.3 Lipid Nanocapsules (LNCs) -- 3.2.3 Protein-Based Nanoparticles for Cancer Theranostics -- 3.2.4 Virus like Nanoparticles in Cancer Theranostics -- 3.2.5 Inorganic and Bionanoparticles in Cancer Theranostics -- 3.3 Conclusions and Future Perspectives -- References -- 4: Nanomedicines for Solid Tumors: Current Status, Challenges, and Future Prospects -- 4.1 Introduction -- 4.2 Possible Factors that Initiate Cancer Growth -- 4.2.1 Age -- 4.2.2 Cancer Causing Elements -- 4.2.3 Immunosuppression -- 4.2.4 Infectious Agents -- 4.2.5 Radiation -- 4.3 Tumor Classification Based on Tissue of Origin -- 4.4 Existing Treatment Options Available for Cancer -- 4.5 Description of Solid Tumor -- 4.6 Nanomedicine -- 4.6.1 Unlocking Novel Cancer Applications Exploited in the Field of Nanomedicine -- 4.7 Fabrications of Nanocarrier for Drug Delivery. 4.8 Targeted Delivery of Nanocarrires to the Tumor Niche as Well as Solid Tumor -- 4.8.1 Drug Targeting Mechanisms and Surface Functionalization of Nanocarriers Aiding Nanomedicine Based Technologies in Solid ... -- 4.9 Nanoscience Based Imaging Technologies in the Detection of Solid Tumors -- 4.9.1 Photodynamic Nanomedicine in the Treatment of Solid Tumors -- 4.10 Nanomedicine and Solid Tumor Heterogenecity -- 4.11 Nanomedicine in Solid Tumors: PROS and CONS? -- 4.11.1 PROS -- 4.11.2 CONS -- 4.12 Discussion -- 4.13 Future Perspective -- References -- 5: Nanomaterials for Early Cancer Diagnostics -- 5.1 Introduction -- 5.2 Cancer and Biomarkers -- 5.2.1 Early Detection of Prostate Cancer -- 5.2.2 Early Detection of Breast Cancer -- 5.2.3 Early Detection of Lung Cancer -- 5.2.4 Early Detection of Liver Cancer -- 5.2.5 Early Detection of Oral Cancer -- 5.2.6 Early Detection of Pancreatic Cancer -- 5.2.7 Early Detection of Ovarian Cancer -- 5.2.8 Early Detection of Human Cervical Cancer -- 5.2.9 Early Detection of Bladder Cancer -- 5.2.10 Early Detection of Head and Neck Cancer -- 5.2.11 Early Detection of Colon Cancer -- 5.3 Conclusion -- References -- 6: Role of Nanomedicine for Cancer Immunotherapy -- 6.1 Introduction -- 6.2 Improving Cellular-Mediated Immunotherapy -- 6.2.1 Combining Therapeutic Agents to Immune Cells -- 6.2.2 Directing Therapeutic Drugs to Immune Cells -- 6.2.3 Delivery of Gene in Lymphocytes -- 6.3 Delivery Mechanism of Nanoparticle Therapeutics -- 6.3.1 Stimulating Immunogenic Cell Death (ICD) -- 6.3.1.1 Nanosized Drug Carriers -- 6.3.1.2 Nanopulse Stimulation -- 6.3.2 Enhanced Presentation of Ligands to Immune Cells -- 6.3.3 Chronological Regulation of Immunostimulation -- 6.4 Modulation in Pharmacokinetics of Immunotherapy Agents -- 6.5 Targeting Myeloid Cells -- 6.6 Targeting Stromal Cell in TME. 6.7 Limitations of Nanomedicines in Cancer Immunotherapy -- 6.8 Conclusion and Future Perspectives -- References -- 7: Targeting Tumor Microenvironment Through Nanotheranostics -- 7.1 Introduction -- 7.2 The Tumor Microenvironment (TME) and its Components -- 7.2.1 Cells of the Immune System -- 7.2.1.1 The T Cells -- 7.2.1.2 The B Cells -- 7.2.1.3 Tumor Associated Macrophages (TAMs) -- 7.2.1.4 Tumor Associated Neutrophils (TANs) -- 7.2.1.5 Natural Killer (NK) Cells -- 7.2.1.6 Cancer Associated Fibroblasts (CAFs) -- 7.2.2 The Extracellular Matrix (ECM) and Surrounding Cells -- 7.2.2.1 The Adipocytes -- 7.2.2.2 The Pericytes -- 7.2.2.3 Matrix Metalloproteases (MMPs) and Other Proteases -- 7.2.2.4 The Endothelial Cells -- 7.2.3 The TME, Inflammation, and Cancer -- 7.2.4 Hypoxia in the TME -- 7.3 The TME as an Attractive Therapeutic Target in Cancer -- 7.4 Cancer Nanotheranostic Agents that Target the TME -- 7.4.1 Metallic Nanoparticles (NPs) -- 7.4.2 Magnetic Nanoparticles (MNPs) -- 7.4.3 Mesoporous Silica Nanoparticles (MSiNPs) -- 7.4.4 Nano-Graphenes (NGs) -- 7.4.5 Polymeric-Based Nanotheranostic Particles (PNPs) -- 7.4.6 Lipid-Based Nanotheranostic Particles (LNPs) -- 7.4.7 Protein-Based Nanotheranostic Particles (PNPs) -- 7.4.8 Viral-Based Nanotheranostic Particles (VLPs) -- 7.4.9 DNA-Based Cancer Nanotheranostic Platform -- 7.5 Visualizing Cancer Through Nanotheranostics -- 7.5.1 Magnetic Resonance Imaging (MRI) -- 7.5.2 Photoacoustic Imaging (PAI) -- 7.5.3 Optical Imaging -- 7.5.4 Nuclear Imaging -- 7.6 Nanotheranostics for the Detection of Cancer Biomarkers -- 7.6.1 Labeling Nanoparticles with Conjugates -- 7.6.1.1 Chemical Crosslinking -- 7.6.1.2 Biotin/Avidin Conjugation -- 7.6.1.3 Click Chemistry -- 7.6.2 Target Moieties for Identification of Cancer Biomarkers -- 7.7 Conclusion and Future Direction -- References. 8: Therapeutic Applications of Noble Metal (Au, Ag, Pt)-Based Nanomedicines for Melanoma -- 8.1 Introduction -- 8.1.1 Melanoma -- 8.1.1.1 Global Statistics and Market -- 8.1.1.2 Treatment Strategies -- 8.1.2 Nanotechnology in Melanoma -- 8.1.2.1 Nanoparticles for Melanoma -- 8.1.2.2 PAMAM -- 8.1.2.3 Zinc Oxide Nanoparticle -- 8.1.2.4 Titanium Dioxide Nanoparticle -- 8.1.2.5 Vanadium Pentoxide Nanoparticle -- 8.1.2.6 Copper Prussian Blue Nanoparticle -- 8.2 Importance of Noble Metal Nanoparticles in Biomedicine -- 8.3 Role of Noble Metals (Au, Ag, Pt) in Treatment of Melanoma -- 8.3.1 Gold (Au) Nanoparticles -- 8.3.1.1 Drug Delivery -- 8.3.1.2 Gene Delivery and Immunotherapy -- 8.3.1.3 Biosynthesized Gold Nanoparticles -- 8.3.1.4 Imaging -- 8.3.1.5 Photothermal and Photodynamic Therapy -- 8.3.2 Silver (Ag) Nanoparticles -- 8.3.3 Platinum (Pt) Nanoparticles -- 8.4 Toxicity of Noble Metal Nanoparticles -- 8.5 Challenges and Future Perspectives -- 8.6 Conclusion -- References -- 9: Ethics in Nanomedicine -- 9.1 Introduction -- 9.2 Nanomedicine -- 9.3 Difference Between Nanotechnology and Nanomedicine -- 9.4 Hype Versus Reality of Nanomedicine -- 9.5 Nondiscrimination and Integrity of Nanomedicine -- 9.6 The Potentiality of Nanomedicine -- 9.7 Biocompatibility and Toxicity of Nanostructures -- 9.8 Demand of the Nanomedicine in Market -- 9.9 Nanomedicine and Ethical Concerns -- 9.9.1 Ethical Problems Associated with Translational Research Involving Nanomedicine -- 9.9.2 Ethical Problems in Personalized and Regenerative Therapy with Nanomedicine -- 9.9.3 Ethical Concerns of Medical Surveillance -- 9.9.4 Ethical Challenges Inherent to Nanomedicine Applications -- 9.9.5 Social Ethics in Public Health Systems -- 9.9.5.1 Impact of Nanotechnology in Developing Nations -- 9.9.5.2 Impact of Nanotechnology on Laborers and Managerial Issues. 9.10 Future Perspectives. |
| Record Nr. | UNINA-9910488707403321 |
| Gateway East, Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine for drug delivery and therapeutics [[electronic resource] /] / edited by Ajay Kumar Mishra
| Nanomedicine for drug delivery and therapeutics [[electronic resource] /] / edited by Ajay Kumar Mishra |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, Inc., 2013 |
| Descrizione fisica | 1 online resource (532 p.) |
| Disciplina | 615.1 |
| Altri autori (Persone) | MishraAjay Kumar <1965-> |
| Soggetto topico |
Nanomedicine
Drug delivery systems Therapeutics |
| ISBN |
1-118-63584-1
1-118-63629-5 1-283-99382-1 1-118-63588-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | pt. 1. Nanomedicine -- pt. 2. Drug delivery and therapeutics. |
| Record Nr. | UNINA-9910141494503321 |
| Hoboken, N.J., : John Wiley & Sons, Inc., 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine in Treatment of Diseases [[electronic resource] /] / edited by Bushra Akhtar, Faqir Muhammad, Ali Sharif
| Nanomedicine in Treatment of Diseases [[electronic resource] /] / edited by Bushra Akhtar, Faqir Muhammad, Ali Sharif |
| Autore | Akhtar Bushra |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (400 pages) |
| Disciplina | 610.72 |
| Altri autori (Persone) |
MuhammadFaqir
SharifAli |
| Collana | Learning Materials in Biosciences |
| Soggetto topico |
Medicine - Research
Biology - Research Medical sciences Pharmacy Nanomedicine Biomedical Research Health Sciences Nanomedicine and Nanotoxicology |
| ISBN | 981-9976-26-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | SECTION-I. INTRODUCTION TO NANOMEDICINE -- Chapter-I. Nanomedicine: Present perspectives and future challenges -- Chapter-II. Advantages of Nanomedicine over Conventional Therapeutics -- SECTION-II. NANOMEDICINE IN TREATMENT OF DISEASES -- Chapter-III. Nanomedicines for the treatment of bacterial diseases -- Chapter-IV. Nanomedicine in the treatment of viral diseases -- Chapter-V. Nanomedicines in the treatment of nervous system disorders -- Chapter-VI. Nanomedicines in treatment of cancer -- Chapter-VII. Nanomedicine in the treatment of Metabolic diseases -- Chapter-VIII. Nanomedicines in the Treatment of Fungal Diseases -- Chapter-IX. Nanomedicines in the treatment of skin diseases -- Chapter-X. Nanomedicines in the treatment of gastrointestinal disorders -- Chapter-XI. Nanomedicines in Treatment of Cardiovascular Diseases -- SECTION-III. CURRENT STATUS OF NANOMEDICINE IN CLINICAL APPLICATIONS -- Chapter-XII. Current status of nanomedicines in clinical practice. |
| Record Nr. | UNINA-9910806191803321 |
Akhtar Bushra
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine journal
| Nanomedicine journal |
| Pubbl/distr/stampa | Mashhad, : Mashhad University of Medical Sciences |
| Descrizione fisica | 1 online resource |
| Soggetto topico | Nanomedicine |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Biomedical Engineering |
| ISSN | 2322-5904 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996320887703316 |
| Mashhad, : Mashhad University of Medical Sciences | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Nanomedicine journal
| Nanomedicine journal |
| Pubbl/distr/stampa | Mashhad, : Mashhad University of Medical Sciences |
| Descrizione fisica | 1 online resource |
| Soggetto topico | Nanomedicine |
| Soggetto genere / forma |
Periodical
Periodicals. |
| Soggetto non controllato | Biomedical Engineering |
| ISSN | 2322-5904 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910142028003321 |
| Mashhad, : Mashhad University of Medical Sciences | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine research journal
| Nanomedicine research journal |
| Pubbl/distr/stampa | Tehran, Iran : , : Iranian Society of Nanomedicine, , [2016]- |
| Descrizione fisica | 1 online resource : illustrations |
| Soggetto topico | Nanomedicine |
| Soggetto genere / forma |
Periodicals.
Zeitschrift |
| ISSN | 2476-7123 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | NMRJ |
| Record Nr. | UNINA-9910250052403321 |
| Tehran, Iran : , : Iranian Society of Nanomedicine, , [2016]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicine research journal
| Nanomedicine research journal |
| Pubbl/distr/stampa | Tehran, Iran : , : Iranian Society of Nanomedicine, , [2016]- |
| Descrizione fisica | 1 online resource : illustrations |
| Soggetto topico | Nanomedicine |
| Soggetto genere / forma |
Periodicals.
Zeitschrift |
| ISSN | 2476-7123 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | NMRJ |
| Record Nr. | UNISA-996321380403316 |
| Tehran, Iran : , : Iranian Society of Nanomedicine, , [2016]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Nanomedicines / / edited by Muhammad Akhyar Farrukh
| Nanomedicines / / edited by Muhammad Akhyar Farrukh |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , 2019 |
| Descrizione fisica | 1 online resource (114 pages) |
| Disciplina | 610.28 |
| Soggetto topico | Nanomedicine |
| ISBN |
1-83962-018-8
1-78985-284-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317763103321 |
| [Place of publication not identified] : , : IntechOpen, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nanomedicines for the Prevention and Treatment of Infectious Diseases [[electronic resource] /] / edited by Vandana B. Patravale, Abhijit A. Date, Anil B. Jindal
| Nanomedicines for the Prevention and Treatment of Infectious Diseases [[electronic resource] /] / edited by Vandana B. Patravale, Abhijit A. Date, Anil B. Jindal |
| Autore | Patravale Vandana B |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (415 pages) |
| Disciplina | 362.1969 |
| Altri autori (Persone) |
DateAbhijit A
JindalAnil B |
| Collana | AAPS Advances in the Pharmaceutical Sciences Series |
| Soggetto topico |
Pharmaceutical chemistry
Nanomedicine Diseases Nanobiotechnology Pharmacology Pharmaceutics Nanomedicine and Nanotoxicology |
| ISBN | 3-031-39020-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Nanocarriers for delivery of peptide antibiotics -- NANOMEDICINES FOR THE PULMONARY DELIVERY OF ANTIBIOTICS -- Inhalable nanomedicines for the treatment of pulmonary aspergillosis -- Nanomedicines for the treatment of systemic candidiasis -- Nanomedicine for the treatment of vaginal candidiasis -- Nanomedicines for the treatment of veterinary parasitic infections -- Role of Nanotechnology Against Malaria: Current Perspectives and Strategies -- NANOMEDICINES FOR THE TREATMENT OF TRYPANOSOMIASIS -- Nanomedicines to improve oral delivery of antiretroviral drugs -- Nano-Adjuvants -- Nanoscale Vaccines for Influenza -- Nano-scale vaccines for the prevention of hepatitis B virus infection -- Nanoscale Vaccines for the Prevention of COVID-19. |
| Record Nr. | UNINA-9910760292003321 |
|
Patravale Vandana B
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Nanomedicine
(205)
- Nanotechnology (37)
- Drug delivery systems (15)
- Nanomedicine and Nanotoxicology (15)
- Nanostructured materials (13)